Next Article in Journal
Activation of mGluR5 and NMDA Receptor Pathways in the Rostral Ventrolateral Medulla as a Central Mechanism for Methamphetamine-Induced Pressor Effect in Rats
Next Article in Special Issue
Asiatic Acid, Extracted from Centella asiatica and Induces Apoptosis Pathway through the Phosphorylation p38 Mitogen-Activated Protein Kinase in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells
Previous Article in Journal
Combined Kinetin and Spermidine Treatments Ameliorate Growth and Photosynthetic Inhibition in Vigna angularis by Up-Regulating Antioxidant and Nitrogen Metabolism under Cadmium Stress
Previous Article in Special Issue
Mechanistic Pathways and Molecular Targets of Plant-Derived Anticancer ent-Kaurane Diterpenes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects?

1
National Center of Supervision Inspection on Processed Food & Food Additives Quality, Nanjing Institute of Product Quality Inspection, Nanjing 210019, China
2
School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, China
3
School of Life Sciences, Nanjing University, Nanjing 210023, China
*
Authors to whom correspondence should be addressed.
Biomolecules 2020, 10(1), 146; https://doi.org/10.3390/biom10010146
Submission received: 1 December 2019 / Revised: 13 January 2020 / Accepted: 14 January 2020 / Published: 16 January 2020
(This article belongs to the Special Issue Phytochemical Omics in Medicinal Plants)

Abstract

:
The toxic reactive aldehyde 4-hydroxynonenal (4-HNE) belongs to the advanced lipid peroxidation end products. Accumulation of 4-HNE and formation of 4-HNE adducts induced by redox imbalance participate in several cytotoxic processes, which contribute to the pathogenesis and progression of oxidative stress-related human disorders. Medicinal plants and bioactive natural compounds are suggested to be attractive sources of potential agents to mitigate oxidative stress, but little is known about the therapeutic potentials especially on combating 4-HNE-induced deleterious effects. Of note, some investigations clarify the attenuation of medicinal plants and bioactive compounds on 4-HNE-induced disturbances, but strong evidence is needed that these plants and compounds serve as potent agents in the prevention and treatment of disorders driven by 4-HNE. Therefore, this review highlights the pharmacological basis of these medicinal plants and bioactive compounds to combat 4-HNE-induced deleterious effects in oxidative stress-related disorders, such as neurotoxicity and neurological disorder, eye damage, cardiovascular injury, liver injury, and energy metabolism disorder. In addition, this review briefly discusses with special attention to the strategies for developing potential therapies by future applications of these medicinal plants and bioactive compounds, which will help biological and pharmacological scientists to explore the new vistas of medicinal plants in combating 4-HNE-induced deleterious effects.

Graphical Abstract

1. Introduction

The toxic reactive aldehyde 4-hydroxynonenal (4-HNE) belongs to the advanced lipid peroxidation end products [1]. As the second toxic messenger of free radicals, 4-HNE modifies specific amino acid residues on proteins to form highly cytotoxic reactive 4-HNE adducts via Michael addition or Schiff base reaction or reacts with DNA via epoxidation under oxidative stress conditions. Oxidative stress is one of the main pathogeneses for human disorders [2]. Accumulation of 4-HNE and formation of 4-HNE adducts are induced by mainly reactive oxygen species (ROS) and other free radicals; participate in several cytotoxic processes such as protein dysfunction, apoptosis, and inflammatory injury; and produce deleterious effects [2,3,4,5,6,7,8]. As a result, 4-HNE serves as a biomarker for both lipid peroxidation and oxidative stress [1,2]. Therefore, the inhibition, neutralization, and detoxification of 4-HNE and 4-HNE adducts has become one of the directions of developing potential therapies for oxidative stress-related disorders.
Medicinal plants have been widely used to prevent and treat various kinds of disorders for thousands of years. Their extracts and bioactive compounds have the ability to prevent the cells from oxidative stress injury [9,10,11]. Some of them have been suggested to be attractive sources of potential agents to mitigate oxidative stress and attenuate 4-HNE-induced toxicity. However, researchers pay little attention to reviewing these medicinal plants and natural bioactive compounds on combating 4-HNE-induced deleterious effects in neurotoxicity and neurological disorder, eye damage, cardiovascular injury, liver injury, and energy metabolism disorder [12,13,14,15,16].
Therefore, this review focuses on the therapeutic effects of medicinal plants in treating 4-HNE-related disorders under oxidative stress. An open-ended, English-restricted search of PubMed/MEDLINE database and Web of Science database has been conducted (up to 31 December 2019) using terms such as 4-HNE-induced or driven/induced by 4-HNE, and medicinal plant/herb/phytochemical/natural compounds compound/constituent. This review aims to highlight the pharmacological basis of medicinal plants and bioactive compounds in the attenuation of 4-HNE-induced deleterious effects, as well as the underlying molecular mechanisms. Additionally, this review briefly discusses the strategies for developing potential therapies in future applications of these medicinal plants and compounds, which will benefit biological and pharmacological scientists to explore the new vistas of medicinal plants in combating 4-HNE-induced deleterious effects.

2. Neuroprotection

Neurotoxicity exacerbated by oxidative stress is strongly associated with 4-HNE toxicity; its further deterioration cleaves nuclear enzyme poly (ADP-ribose) polymerase (PARP) to affect DNA repair and apoptosis in neurons, leading to neurological disorders [1,17]. Polyphenol extract from red wine offers health benefits and can help to avoid neurodegenerative diseases [18]. This extract inhibits 4-HNE-induced cleavage of PARP and protects against apoptosis in neuronal-like catecholaminergic cells (rat pheochromocytoma, PC12 cells) by reducing intracellular ROS [19]. Polyphenolic flavonoids quercetin and myricetin isolated from red wine extract or Ginkgo biloba extract have cytoprotective effects on 4-HNE-induced PC12 cell death [19], further demonstrating the benefits in neurodegeneration [20,21]. Other medicinal plant flavonoids luteolin and apigenin have antioxidant, anti-inflammatory, and neuroprotective effects. These two flavonoid compounds also attenuate 4-HNE-induced PARP-1 and caspase-3 activation as well as cell viability in PC12 cells [22].
The accumulation of 4-HNE up-regulates mitogen-activated protein kinase (MAPK) superfamily, especially C-Jun-N-terminal kinase (JNK), which plays a crucial role in oxidative stress-mediated cellular apoptosis [23,24]. Piceatannol, a bioactive stilbene derivative from medicinal plants Passiflora edulis or Gnetum parvifolium, restores 4-HNE-induced PARP cleavage and apoptosis regulator Bcl-2 expression, and down-regulates the phosphorylation of JNK (p-JNK) in PC12 cell death and nuclear condensation [25]. Recently, maternal supplementation with piceatannol has been demonstrated to have neuroprotection against neonate brain damage and reverse the sensorimotor deficit and cognitive impairment in rats [26]. Additionally, as a traditional medicinal plant in China and Korea, citri reticulatae viride pericarpium also restores 4-HNE-induced inflammatory injury in PC12 cells via inhibiting the activation of p-JNK and nuclear factor kappa-B (NF-κB) [27]. Mitogen-activated protein kinase kinase 4 (MKK4) as an upstream activator of JNK plays a critical role in response to cellular oxidative stress. Cocoa procyanidin fraction and its major antioxidant compound procyanidin B2 are reported to attenuate 4-HNE-induced nuclear condensation and increase sub-G1 fraction (markers of apoptotic cell death) as well as intracellular ROS accumulation in PC12 cells. This fraction and procyanidin B2 also protect against 4-HNE-induced PC12 cell apoptosis by blocking MKK4 activity [28]. Thus, the modulation of JNK and its upstream activator by medicinal plants and bioactive compounds may have potential therapeutic indications for neurodegenerative diseases.
Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2) is a ubiquitous master transcription factor that binds to the antioxidant response elements (ARE) and then enhances the expression levels of antioxidant enzymes and cytoprotective genes within DNA in response to oxidative stress [29]. Trans-resveratrol, a natural stilbene constituent isolated from medicinal plant grapevinele, is known to activate Nrf2 signaling pathway. Trans-resveratrol counters the cytotoxic response of 4-HNE consistently and reduces ROS generation and lipid peroxidation in PC-12 cells, showing its improvement of antioxidant defense system. It also restores 4-HNE-induced protein expression changes of mitochondria-mediated apoptosis markers (caspase-3, Bax, and B-cell lymphoma-2 (Bcl-2)) as well as oxidative damage, resulting in the alleviation of apoptotic neurodegeneration in PC12 cells [30]. More importantly, sulforaphane (an isothiocyanate mainly derived from crucifers such as broccoli, cabbages and olives) and carnosic acid (a plastidial catecholic diterpene mainly from Rosmarinus officinalis) are two phytochemicals Nrf2/ARE activators, which are found to attenuate 4-HNE-induced inhibition of mitochondrial respiration for complex I; the latter has been found to protect complex II in the isolated cortical mitochondria in young adult male CF-1 mice [14]. Furthermore, sulforaphane and carnosic acid decrease the amount of 4-HNE bound to mitochondrial proteins [14]. Microtubule-associated protein 1 light chain 3 alpha (LC3) is a marker of autophagosome, which is required for clearing dead cells. Study has shown that polyphenolic flavonoids luteolin and apigenin mitigate LC3 conversion and ROS production, activate Nrf2 signaling, and inhibit cytotoxicity in 4-HNE-exposed PC12 cells [22]. Therefore, the above phytochemicals have the capability of Nrf2 signaling induction to prevent the mitotoxicity of 4-HNE and provide neuroprotection.
Hyperactivity of NADPH oxidases (NOX) induced by 4-HNE has a crucial role in ROS overproduction and apoptosis; thus, NOX-derived ROS is a central mechanism in the development of neurodegeneration and neuroinflammation [31]. Kaempferol, a natural flavonoid presented in many medicinal plants, has been proved as a potential neuroprotective agent. It suppresses 4-HNE-mediated p-JNK and apoptosis in PC12 cells. Interestingly, kaempferol directly binds p47(phox), a cytosolic subunit of NOX, and effectively blocks 4-HNE-induced NOX activation in PC12 cells, exerting its potential neuroprotection against NOX-mediated neurodegeneration [13]. Scutellarin, a bioactive flavone isolated from Scutellaria baicalensis, has anti-inflammatory, anti-oxidative, anti-apoptotic, and anti-neurotoxic properties. More recently, a molecular docking study showed that scutellarin selectively binds to NOX2 with high affinity. Substantially, scutellarin down-regulates NOX2 expression and reduces 4-HNE and ROS levels in astrocytes subjected to ischemia/reperfusion and in rats with focal cerebral ischemia [32]. These results indicate that scutellarin is a neuroprotective flavone against ischemic injury.
Alzheimer’s disease (AD) is a progressive and irreversible neurodegenerative disorder. High levels of 4-HNE are detected in the AD brain with the induction of neuronal apoptosis and oxidative stress, indicating that 4-HNE may play a role in AD subjects and/or animal models of age-related neurodegenerative disorders [33,34]. Acetylcholine esterase (AChE), cyclooxygenase-2 (COX-2), and matrix metalloproteinase-8 (MMP-8) are important target proteins implicated in AD pathogenesis. Phytocompounds albiziasaponin-A, iso-orientin, and salvadorin have antioxidant and anticholinesterase activities. The results from molecular docking studies show that there are strong interactions of albiziasaponin-A, iso-orientin, and salvadorin with AChE, COX2, and MMP8, respectively. Hence, these three bioactive compounds reduce serum 4-HNE levels in colchicine-induced AD model of rats, suggesting that albiziasaponin-A, iso-orientin, and salvadorin may be potential neuroprotective agents [35].
Glutathione S-transferase (GST) is a critical enzyme that participates in the detoxification of 4-HNE and has potential to prevent degenerative cellular processes [36]. Naringenin, a flavonoid found in grapefruit juice, is reported to improve learning and memory in a rat model of AD [37]. In an intracerebroventricular-streptozotocin-induced AD-type model of rats with cognitive impairment, naringenin increases GST, glutathione peroxidase (GSH-Px), glutathione reductase (GR), superoxide dismutase (SOD), and catalase (CAT) to detoxify 4-HNE in the hippocampus [38]. Collapsin response mediator protein-2 (CRMP-2) is hyperphosphorylated in AD. More recently, using computational tools with structural and dynamic analyses, naringenin and naringenin-7-O-glucuronide have been found to selectively bind CRMP-2 and then reduce p-CRMP-2, being the therapeutic activity of novel CRMP-2 inhibitor [39,40].
In senescence-accelerated mouse prone 8 (SAMP8) model of mice with age-related cognitive decline and AD, rosemary extract as well as spearmint extract (containing carnosic acid and rosmarinic acid) are reported to reduce 4-HNE levels in brain cortex and protein carbonyls in brain hippocampus, resulting in the improvement of learning and memory [41]. More importantly, rosmarinic acid increases antioxidant enzyme activities (such as SOD, CAT, and GSH-Px) and glutathione levels and then reduces 4-HNE in amyloid beta 42-induced echoic memory decline in rats with oxidative stress and cholinergic impairment, possibly contributing to the improvement of neural network dynamics of auditory processes [42]. Dark tea prevents and treats age-related degenerative diseases. l-theanine, 3,3′-azanediylbis (4-hydroxybenzoic acid) and one of 8-C N-ethyl-2-pyrrolidinone substituted flavan-3-ols were recently isolated for in silico characterization of microbial metabolites extracted from dark tea. Oral administration of these three compounds indeed inhibits the formation of 4-HNE and ubiquitinated protein aggregates, regulates Aβ metabolic pathway, increases endogenous antioxidant capacity, and reduces neuronal apoptosis rate in SAMP8 mice, showing the protection of SAMP8 neurons [43].
Parkinson’s disease (PD) is an age-related neurodegenerative disorder that severely affects quality of life. Chrysin, a flavone found in Passiflora caerulea, P. incarnata, and Oroxylum indicum, improves antioxidant defense system to protect against oxidative stress by increasing GSH to reduce 4-HNE. Consistently, chrysin improves behavioral and cognitive ability in a 6-hydroxydopamine-induced mouse model of PD [44]. Quercetin also markedly improves the motor balance and coordination in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced PD of mice. Moreover, quercetin significantly decreases 4-HNE immunoreactivity in striatum of mouse brains and increases GPx, SOD, AchE, and dopamine contents, showing the antiparkinsonian property [45].

3. Prevention of Eye Damage

The main visual ocular structures are the cornea and conjunctiva, lens, vitreum, and retina. Any structure dysfunction can cause visual problems and even blindness. Overproduction of ROS leads to the increased level of 4-HNE and induces lipid oxidative damage and inflammation in the cornea and conjunctiva [46,47], whereas 4-HNE accumulation causes the death of lens epithelia cells to induce lens opacification and cataract [48] as well as retinal pigment epithelium (RPE) cell death [49,50]. In the ocular surface of mouse model with dry eye disease, antioxidant extracts from Schizonepeta tenuifolia, Angelica dahurica, Rehmannia glutinosa, and Cassia tora reduce the number of 4-HNE-positive cells to protect from lipid peroxidation-related membrane damage. These antioxidant extracts also inhibit extracellular ROS production and decrease IL-1β, IL-6, tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) levels of the ocular surface, resulting in the improvement of clinical signs [51].
Aldose reductase (AR, an NADPH-dependent oxidoreductase) hyperactivity in the lens plays an important role in the pathogenesis of oxidative stress-mediated diabetic cataract [52]. Quercetin possesses therapeutic effect in the management and treatment of diabetic cataract. Quercetin and its glycoside derivative rutin, or G. biloba extract, remarkably inhibit AR activity, stimulate GSH production, and decrease the levels of 4-HNE, lipid peroxidation malondialdehyde (MDA), and advanced glycation end-products in the lenses of streptozotocin-induced diabetic cataract rats, delaying the progression of lens opacification [53]. Curcumin, a diketone constituent extracted from Curcuma longa, is a wonderful natural antioxidant and anti-cataract agent. This bioactive compound enhances the formation of GST isoenzymes to detoxify 4-HNE by aiding in the conjugation of 4-HNE to glutathione, showing its prevention against cataract [48].
Proliferative diabetic retinopathy, a leading cause of blindness, is also promoted by 4-HNE. Berberine, an isoquinoline alkaloid from a medicinal plant rhizoma of Coptidis chinesis, has favorable effects on glucose and lipid metabolism in animal experimental and human clinical studies [54]. In confluent human retinal Müller cells exposed to 4-HNE, cell death is partially attenuated by berberine pretreatment. Berberine also restores 4-HNE-induced autophagy in this cell model, showing its potential to prevent diabetic retinopathy [55].
In fact, 4-HNE can destabilize actin and induce cytoskeletal damage, resulting in retinopathy and age-related macular degeneration [56]. Cyanidin-3-glucoside is a major anthocyanin in mulberry or Lonicera caerulea, and its supplement has potential to prevent eye diseases. In human adult retinal pigmented epithelial (ARPE-19) cells, cyanidin-3-glucoside protects against 4-HNE-induced cell apoptosis, inflammatory damage, and angiogenesis [12,57]. Quercetin also increases viability and decreases inflammation and cytotoxicity in 4-HNE-exposed ARPE-19 cells [58]. Recently, solid dispersion of quercetin has been reported to decrease retinal pigment epithelium sediments and Bruch’s membrane thickness in Nrf2 wild-type (WT) mice with dry age-related macular degeneration. This solid dispersion reduces ROS and MDA contents and increases SOD, GSH-PX, and CAT activities in serum and retinal tissues of Nrf2 WT mice. Solid dispersion of quercetin also up-regulates Nrf2 mRNA expression and enhances its nuclear translocation, as well as Nrf2 target gene hemeoxygenase-1(HO-1) in retinal tissues of Nrf2 WT mice [59]. These observations suggest that quercetin may alleviate oxidative injury to prevent dry age-related macular degeneration by enhancing Nrf2 activation. Medicinal plants marigold or grape seed (containing macular pigments lutein and zeaxanthin) are reported to have anti-oxidative activity and prevent 4-HNE adduct formation, actin solubility, and lipofuscin accumulation as well as age-related cone and rod photoreceptor dysfunction in β5(-/-) mice with cytoskeletal damage in aging RPE cells [56]. Of note, 4-HNE release and oxidative damage are also induced by irradiation exposure, causing retinopathy. Cyanidin-3-glucoside and quercetin decrease 4-HNE release in rod outer segments incubated with all-trans-retinal to generate bisretinoid under irradiation [60], whereas lutein and zeaxanthin isomers have recently been demonstrated to protect against light-induced retinopathy by reducing oxidative and endoplasmic reticulum stress in BALB/cJ mice [61]. Photodegradation of N-retinylidene-N-retinylethanolamine (A2E) is known to release reactive carbonyls. Medicinal plant compounds cyanidin-3-glucoside, quercetin, ferulic acid, and chlorogenic acid diminish cellular ROS and protect GSH from the reaction with photooxidized A2E in A2E accumulated-RPE cells irradiated with short-wavelength light [60].
This is especially important in exploring the possible molecular mechanisms by which bioactive compounds prevent 4-HNE-related retinopathy. NOD-like receptor protein 3 (NLRP3) inflammasome activation in the eyes is associated with the pathogenesis of age-related macular degeneration in RPE cells [62]. Cyanidin-3-glucoside has been found to inhibit NLRP3 inflammasome activation by reducing NLRP3, caspase-1, IL-1β, and IL-18 levels in 4-HNE-exposed ARPE-19 cells. This inhibitory mechanism may be mediated by regulating JNK-c-Jun/activator protein 1 (AP-1) pathway, further demonstrating the potential of cyanidin-3-glucoside to prevent retinal degenerative diseases [63,64]. Quercetin improves cell membrane integrity and mitochondrial function and decreases IL-6, IL-8, and monocyte chemotactic protein 1 (MCP-1) production, presumably by regulating MAPK/NF-κB signaling pathway in ARPE-19 cells stimulated by inflammatory cytokine [65].

4. Protection against Cardiovascular Injury

The normal redox status can be altered by 4-HNE adducts, which cause cardiomyocyte damage and vascular dysfunction. Thus, 4-HNE may play a key role in the progression of cardiovascular diseases [5,66,67]. Thymbra capitata is a Mediterranean culinary herb. Its essential oil prevents 4-HNE-induced cell death and avoids mitochondrial membrane potential loss and ROS generation in primary cultures of neonatal rat cardiomyocytes [15]. Olive (Olea europaea) leaf, a popular traditional herbal medicine, has a cardioprotective function. The ethanolic and methanolic extracts of O. europaea are reported to inhibit 4-HNE-induced apoptosis, ROS production, viability impairment, mitochondrial dysfunction, and pro-apoptotic activation in rat cardiomyocyte cell line (H9c2 cells). These extracts also reduce 4-HNE-induced phosphorylation of stress-activated transcription factors in H9c2 cells [68]. Furthermore, phenolic compounds oleuropein, hydroxytyrosol, and quercetin derived from olive leaf are found to prevent against 4-HNE-induced cardiomyocyte carbonyl stress and toxicity and eventually regulate the cellular redox status [68]. Other medicinal plant constituents such as epigallocatechin-3-gallate, sulforaphane, and puerarin are reported to protect against cardiomyopathy. These compounds also reduce 4-HNE and lipid peroxidation to prevent oxidative stress in animal models of cardiovascular injury [69,70,71].
Aldehyde dehydrogenase 2 (ALDH2) mediates detoxification of toxic aldehydes, being necessary and sufficient to confer cardioprotection. Alpha-lipoic acid isolated from spinach and broccoli acts as a free radical scavenger. This bioactive compound activates myocardial ALDH2 and reduces 4-HNE and MDA levels in a Langendorff model of rat ischemia/reperfusion [72]. A recent report shows that α-lipoic acid prominently down-regulates the expression of 4-HNE and NOX subunit p67phox to inhibit oxidative stress in fistula-created deterioration of cardiac function rats [73], further demonstrating the cardioprotective effect. Flavonoid glycoside baicalin, extracted from Scutellaria baicalensis root, protects against hypoxia/reoxygenation-induced H9c2 cell injury. Baicalin also enhances ALDH activity to reduce of 4-HNE and MAD levels and increases SOD activity to suppress ROS production in H9c2 cells, showing its cardioprotection against hypoxia/reoxygenation-induced cardiomyocyte injury [74].
Atherosclerotic lesion is associated with the accumulation of reactive aldehydes derived from oxidized lipids. Accumulation of 4-HNE becomes an important risk factor that contributes to the atherogenicity of oxidized low-density lipoprotein (ox-LDL) and the development of atherosclerosis [75]. G. biloba leaf extract is reported to reduce ox-LDL and attenuate 4-HNE-induced production of matrix metalloproteinase-1 (MMP-1), probably through suppressing the activation of tyrosine-phosphorylated form of platelet-derived growth factor receptor beta in human coronary smooth muscle cells [76]. Medicinal plant Opuntia cladodes powder containing phenolic acid and flavonoids also reduces ox-LDL and 4-HNE toxicity in normal (Apc +/+) and preneoplastic (Apc min/+) immortalized epithelial colon cells [77]. Moreover, O. cladodes significantly reduces the formation of atherosclerotic lesions and the accumulation of 4-HNE adducts in the vascular wall of apoE-KO mice [78]. These observations demonstrate that O. cladodes may have therapeutic potential in 4-HNE-related cardiovascular diseases.

5. Protection against Liver Injury

There is evidence that the increased level of 4-HNE is correlated with the pathogenesis of liver injury [2,79]. Ginseng is a well-known medicinal plant. Ginseng extracts exert protection against liver injury via multiple pathways. For example, the fine root extract of ginseng with ginsenosides profiles has been found to attenuate 4-HNE-induced DNA damage in HepG2 cells. Methanolic extract of the main root also shows a decrease of DNA damage in this cell model [80]. Water extract of P. ginseng, rich in ginsenosides Rg1 and Rb1, significantly reduces total ROS generation and especially down-regulates 4-HNE signals in radiation-induced steatohepatitis of mice [81]. Red ginseng or black ginseng is a type of the repeated steam-processed P. ginseng. Red ginseng extract improves chronic alcohol-induced histopathological changes of liver in mice. This extract also inhibits oxidative stress and lipid peroxidation by reducing the formation of 4-HNE and the number of 4-HNE-positive cells and protects hepatocytes from inflammation and necrosis by activating AMP-activated protein kinase (AMPK)/Sirt1 pathway [82]. Recently, black ginseng extract has been reported to maintain the cellular redox status by restoring NOX and GSH level change and alleviate oxidative stress by reducing intracellular ROS production and lipid peroxide 4-HNE signals, resulting in the protection of hydrogen peroxide-induced oxidative damage in AML-12 cells [83]. American ginseng berry, the ripe fruit of Panax quinquefolius, contains a variety of protopanaxadiol ginsenosides and protopanaxatriol ginsenosides. This ripe fruit extract inhibits alanine aminotransferase and aspartate transaminase activity and mitigates oxidative stress and lipid peroxidation by reinforcing SOD activity, suppressing GSH depletion, and reducing 4-HNE formation in acetaminophen-induced liver injury of mice [84].
Several other bioactive compounds of medicinal plants also mitigate oxidative stress, improve antioxidant function, and reduce 4-HNE, protecting against liver injury. Tanshinone II-A is a diterpene quinone constituent of Salvia miltiorrhiza. This bioactive compound restores 4-HNE-induced hepatocyte damage in normal liver tissue NCTC 1469 cells. Tanshinone II-A also up-regulates peroxisome proliferator-activated receptor α (PPARα) expression and scavenges 4-HNE in this hepatocyte model [85]. Fisetin, one of the most popular polyphenols in fruits and vegetables, exhibits senotherapeutic activity in treating aged mice. It reduces liver oxidative stress damage by decreasing 4-HNE adducts and increasing the ratio of intracellular oxidized glutathione [86,87]. p-Coumaric acid, rich in fruits, vegetables, and plants, protects hepatocytes against oxidative stress and lipid peroxidation efficiently by reducing high levels of ROS and formation of 4-HNE protein adducts. Consistently, this active compound attenuates acetaminophen-induced hepatotoxicity, apoptosis, and inflammation in mice by suppressing the translocation of apoptosis-inducing factor and MAPK signaling and decreasing NF-κB activity [88]. Chlorogenic acid is an active compound in Ligustrum lucidum fruit that protects hepatocyte mitochondria from oxidative stress mediated by the activation of AMPK in carbon tetrachloride-induced acute liver injury of mice [89]. Water extract of L. lucidum inhibits ROS generation and increases intracellular GSH to reduce 4-HNE levels in this animal model, demonstrating that L. lucidum inhibits oxidative stress to prevent liver injury via AMPK activation [89].
Of note, high 4-HNE levels cause rapid cell death associated with the depletion of sulfhydryl groups and inhibition of key metabolic enzymes. Aldo-keto reductase family 7 member A2 (AKR7A2) is the most abundant anthracycline metabolizing enzyme, which has been found to protect against 4-HNE toxicity. AKR7A2 over-expression rescues the effect of Nrf2-knockdown on 4-HNE-induced cytotoxicity [90]. The active coumarin compound 7-Hydroxycoumain is presented in many medicinal plants, such as the seeds of Clausena lansium, Parasenecio forrestii, Artemisia argyi, and Pharbitis purpurea. This phytochemical acts as an AKR7A2 inducer and protects against 4-HNE-induced HepG2 cell damage via AKR7A2 induction. Thus, the inducible AKR7A2 has provided a new therapeutic target to treat oxidative stress-related chronic liver disease [90]. Additionally, the effects of bioactive compounds on AR activity have been reported. Plant triterpenoid saponins soyasaponin Ba (V), soyasaponin Bb, soyasaponin Bd (sandosaponin A), soyasaponin αg, 3-O-[R-L-rhamnopyranosyl (1→2)-α-D-glucopyranosyl (1→2)-α-D-glucuronopyranosyl]olean-12-en-22-oxo-3α,-24-diol, and soyasaponin βg isolated from methanolic extract of Phaseolus vulgaris seeds (Zolfino bean) have the ability to inhibit highly purified human recombinant aldose reductase (hAKR1B1), as well as hAKR1B1-dependent reduction of 4-HNE [91]. This work suggests that the reduction of 4-HNE by metabolic enzymes is an important determinant of the prevention of oxidative stress-driven liver injury.

6. Improvement of Energy Metabolism Disorder

Oxidative stress induced by 4-HNE also causes energy metabolism disorder that leads to tissue injury [92,93,94]. A harmful effect is exerted on adipocytes by 4-HNE, and 4-HNE also promotes insulin resistance [92,95,96]. In fact, 4-HNE induction and its lipolytic response are observed in insulin resistance patients with obesity and type 2 diabetes mellitus [92]. Insulin signaling pathway plays an important role in mediating energy metabolism. Tocotrienol-rich fraction in olive oil is reported to protect against oxidative stress, inflammation, and apoptosis, prevent the increased levels of 4-HNE and protein carbonyls from hyperglycemia-induced muscle damage, and effectively reduce insulin resistance in type 2 diabetic mice, via regulating the AMPK/Sirt1/peroxisome proliferator-activated receptor γ coactivator 1 (PGC1) pathway [97]. Carnosic acid decreases 4-HNE-mediated free fatty acid release and activates Tyr632 phosphorylation of insulin receptor substrate-1 (p-IRS-1Tyr632) and protein kinase B (p-Akt), inhibits as well as p-IRS-1Ser307 in insulin signaling pathway in 3T3-L1 adipocytes. This rosemary diterpene compound also suppresses 4-HNE-induced phosphorylation of protein kinase A (p-PKA) and hormone-sensitive lipase (HSL) and attenuates 4-HNE-induced down-regulation of p-AMPK and acetyl-CoA carboxylase, demonstrating the alleviation of insulin resistance driven by 4-HNE [16].
The improvement of antioxidant defense system in treating energy metabolism disorders is also important. GST can protect against 4-HNE-induced insulin resistance [36]. Carnosic acid up-regulates GST expression to reduce 4-HNE-conjugated proteins, being consistent with its attenuation of 4-HNE-induced lipolytic response and insulin resistance [16]. Morus alba (mulberry), a popular ornamental plant, has several well-documented beneficial effects to prevent and treat metabolic diseases [98]. The root bark extract of M. alba, rich in Diels–Alder type adducts cudraflavone B and other flavonoids, markedly protects against lipid peroxidation-induced pancreatic injury by increasing GSH and reducing 4-HNE in rats [99]. Mulberry leaf contains a variety of flavonoids to control obesity [100]. Recent study shows that mulberry leaf aqueous extract significantly reduces plasma levels of 4-HNE adducts and enhances the cellular antioxidant defense system to inhibit oxidative stress via normalizing Nrf2 activation in high fat diet-fed mice [101]. Mulberry fruits, a well-known source of resveratrol, prevent diabetic complications by reducing lipid peroxidation and 4-HNE accumulation in diabetic pregnancy [102]. Consistently, mulberry bioactive compound trans-resveratrol mitigates oxidative stress by reducing lipid peroxidation and inhibiting 4-HNE expression and DNA damage in streptozotocin-induced type 1 diabetes of rats [103]. In addition, the inhibition of NOX plays a key role in the mitigation of oxidative stress and prevention of insulin resistance, steatosis, and muscle damage [104,105]. NOX inhibitor apocynin, isolated from Picrorhiza kurroa, has been found to attenuate insulin resistance in skeletal muscle of mice with metabolic syndrome. Another phytochemical, (−)-epicatechin, found in green tea and cocoa, also down-regulates NOX1/NOX4, reduces 4-HNE adducts from ileum cells, and mitigates high fat diet-induced insulin resistance and steatosis in male C57BL/6J mice by preventing oxidative stress [106]. Cyanidin and delphinidin are the most common aglycon forms of anthocyanins and also have NOX inhibitory activity to attenuate high fat-induced steatosis and control the adverse effects by reducing 4-HNE-protein adducts in mice [107].
Another risk factor of obesity and type 2 diabetes is increased following exposure to fine particular matter (PM2.5) [108,109,110]. Research has shown 4-Hydroxytyrosol to be beneficial for metabolic and cardiovascular disorders. It also reduces liver and serum 4-HNE levels and alleviates PM2.5-induced, adiposity, and insulin resistance in adult female C57BL/6j mice by mitigating oxidative stress as well as restraining NF-κB activation and gut microbiota [111]. Additionally, there is evidence that 4-hydroxytyrosol significantly reduces 4-HNE expression in red blood cells from hyperlipemic patients and protects red blood cells against 4-HNE toxicity [112].

7. Amelioration of Other Disorders

Medicinal plants and bioactive compounds also combat 4-HNE-induced deleterious effects and ameliorate the clinical signs in other disorders. Aloe vera is a medicinal herb that contains numerous bioactive components. Aqueous extract of A. vera has an antioxidant capacity on endogenous ROS production and 4-HNE-protein adducts induced by 4-HNE in human cervical cancer (HeLa), human microvascular endothelial cells (HMEC), human keratinocytes (HaCat), and human osteosarcoma (HOS) cell cultures [113]. Triterpene saponin aescin isolated from Aesculus hippocastanum restricts lipid peroxidation to reduce cytotoxic 4-HNE levels and keeps more neurons and myelin sheaths alive in the spinal cord injury of rats, which may be mediated by enhancing HO-1 expression and inhibiting NF-κB activation [114,115]. Natural anti-oxidation compounds capsaicin (chili peppers), curcumin (turmeric), and polyphenols as well as G. biloba and Polypodium leucotomos are reported to inhibit 4-HNE-induced oxidative stress in human melanocytes, resulting in the inhibition of cell apoptosis [116]. Rutin effectively decreases 4-HNE and increases GSH-Px and GSH; thus, it prevents against UV-induced skin fibroblast membrane disruption via the regulation of antioxidant system [117]. Ascorbic acid has a similar effect in reducing 4-HNE levels in human skin fibroblasts exposed to UV radiation and hydrogen peroxide [118].
Additionally, 4-HNE is reported to disrupt gap junction-mediated intercellular communication in the lateral wall structures of the cochlea [119]. Some medicinal plant constituents such as astragaloside IV, baicalein, catalpol, curcumin, kaempferol, luteolin, quercetin, resveratrol, and rosmarinic acid are reported to prevent hair cell death [120]. Astragaloside IV (the major constituent of Astragalus membranaceus) significantly down-regulates 4-HNE expression in guinea pig cochlea exposed to impulse noise, being consistent with the attenuation of impulse noise-induced trauma [121,122]. Rosmarinic acid enhances the endogenous antioxidant defense and decreases 4-HNE expression by the regulation of the Nrf2/HO-1 signaling pathway, resulting in the attenuation of noise-induced hearing loss and injury in rat cochlea [123]. Therefore, these natural compounds may be the effective therapy to ameliorate 4-HNE-driven hearing loss.
During food digestion, the absorption of highly toxic 4-HNE from the gastrointestinal tract into the blood system may contribute to the development of multiple oxidative stress-related disorders [124]. Polyphenol-rich beverages such as Japanese Sencha green tea and grape juice promote the stability of polyunsaturated fatty acids to oxidation and inhibit 4-HNE formation during the simulated digestion of linseed oil emulsions in the intestinal phase [125]. Algae (microalgae Schizochytrium sp.), the division of lower plants, also has pharmaceutical applications. Algae oil, rich in phenolic compounds β-carotene and tocopherols, is reported to prevent lipid peroxidation and inhibit 4-HNE formation in digestion during both in vitro gastric and duodenal digestions [126]. (−)-epicatechin also restores fat diet-induced increase of intestinal permeability, down-regulation of ileal tight junction proteins, as well as reduction of endotoxemia, being consistent with the improvement of insulin resistance. More importantly, (−)-epicatechin and apocynin are found to suppress NOX1/NOX4 overexpression, 4-HNE adducts and monolayer permeabilization by regulating redox sensitive signals in TNFα-exposed Caco-2 cells, further demonstrating the protection against the high fat diet-induced increased intestinal permeability. These results are consistent with the prevention of steatosis and insulin resistance under the treatment of (−)-epicatechin and apocynin [106]. The edible amaranth plants from around the world have strong antioxidant activity [127]. Clinical study shows that the supplementation of amaranth seed oil in addition to standard anti-helicobacter pylori treatment significantly decreases the accumulation of 4-HNE-histidine adducts in gastric mucosa and increases heart rate variability in duodenal peptic ulcer patients. Therefore, the standard treatment of duodenal peptic ulcer requires additional therapeutic approaches by using amaranth seed oil [128].
Energy metabolism disorders induced by 4-HNE may alter longevity by orchestrating the development of a biological phenotype. Plant fruits rich in high levels of antioxidants can promote longevity and health span. For example, the supplementation with 4% nectarine has been found to extend life and increase fecundity. Nectarine reduces 4-HNE-protein adduct in wild-type females fed with high-fat diet. Moreover, nectarine ameliorates aging-related death and reduces oxidative damage in female sod1-mutant flies [129]. These results demonstrate that the attenuation of 4-HNE-induced energy metabolism disorders by medicinal plants and bioactive compounds may promote longevity.

8. The Strategy for Developing Potential Therapy

As a toxic end-product of lipid peroxidation, 4-HNE is an important mediator in physiological adaptive reaction and signal transport, as well as in the pathogenesis of multiple oxidative stress-related disorders. Medicinal plants and bioactive compounds are found to enhance metabolism, detoxification or clearance of 4-HNE by regulating activities of endogenous enzymes (such as AR, GST, and AKRs), which may provide the effective strategies for combating 4-HNE-driven deleterious effects. Because of differential metabolisms of 4-HNE observed in liver, lung, and brain of rodents [130], further study is warranted to determine whether these medicinal plants and bioactive compounds have the capacity to mediate oxidative, reductive, and conjugative pathways to metabolize 4-HNE and 4-HNE adducts in oxidative stress-triggered injury of these tissues.
The Nrf2/ARE pathway is suggested to mediate the adaptive induction of antioxidant and detoxifying enzymes including GST and AKR1C1, resulting in the metabolism of 4-HNE [131]. The capability of the Nrf2/ARE pathway induction may constitute a pleiotropic cytoprotective defense to prevent 4-HNE toxicity. Ongoing studies will determine the therapeutic effects of Nrf2/ARE activators derived from medicinal plants and bioactive compounds to mitigate 4-HNE cytotoxicity-induced pathophysiology of disorders or diseases.
Of note, PPARα modulates several biological processes that are perturbed in energy homeostasis [132]. A recent report shows that PPARα is unable to block β-catenin transcriptional activity induced by a constitutively active mutant of lipoprotein receptor-related protein 6 (LRP6). In fact, 4-HNE-induced ROS production enhances LRP6 stability; this event is inhibited by PPARα overexpression [133]. It is known that anti-obesity hormone leptin signaling as well as insulin signaling mediate the regulation of PPARα. Insulin resistance is improved by 4-HNE [96], which also selectively inhibits leptin signaling, possibly promoting the pathogenesis of leptin resistance in obesity [134]. Some medicinal plants and natural compounds acting on PPARα, leptin, or insulin signaling may be responsible for the therapeutic effects on 4-HNE-induced energy metabolism disorders [85].
However, several important issues related to 4-HNE-driven molecular events in diseases, or the relevance of medicinal plants and bioactive compounds in redox homeostasis, still need more studies and new comprehensive approaches. In this regard, preclinical studies and clinical intervention trials are required, which should include the use of accurate analytical techniques, such as the determination of 4-HNE and 4-HNE adducts by immunohistochemistry and enzyme-linked immunosorbent assay, as well as matrix-assisted laser desorption/ionization–tandem time of flight (MALDI–TOF/TOF) mass spectrometry and liquid chromatography–tandem mass spectrometry (LC–MS/MS) [135,136,137,138].

9. Conclusions and Future Perspectives

As a biomarker of lipid peroxidation and oxidative stress, cytotoxic 4-HNE contributes to the progression of oxidative stress-related disorders. Some medicinal plants and bioactive compounds have been demonstrated to reduce 4-HNE levels, detoxify 4-HNE, and inhibit 4-HNE adduct formation through the up-regulation of the antioxidant enzymes and suppression of 4-HNE-mediated downstream signals. More experiments have proved that these medicinal plants and bioactive compounds combat 4-HNE-induced deleterious effects in oxidative stress-related neurological disorder, eye damage, cardiovascular injury, liver injury, energy metabolism disorder, and other disorders (Table 1). The understanding of the molecular basis for the function of medicinal plants and bioactive compounds would be useful to facilitate the selection of 4-HNE metabolism for future intervention investigation and health claim support and develop new treatment for 4-HNE-induced deleterious effects in these disorders. Moreover, the identification and analysis of 4-HNE and 4-HNE adducts are necessary to further support the association between medicinal plants and oxidative stress-related disorders in clinical trials.

Author Contributions

Conceptualization, F.-X.W. and L.-D.K.; software, F.-X.W.; writing—original draft preparation, F.-X.W., H.-Y.L., and Y.-Q.L.; review and editing, F.-X.W. and H.-Y.L.; revising, L.-D.K. and F.-X.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declared no conflict of interest.

Abbreviations

4-HNE4-hydroxynonenal
ROSreactive oxygen species
PARPpoly (ADP-ribose) polymerase
PC12 cellsneuronal-like catecholaminergic cells (rat pheochromocytoma)
Nrf-2nuclear factor (erythroid-derived 2)-like-2 factor
AREantioxidant response elements
Bcl-2B-cell lymphoma-2
LC3protein 1 light chain 3 alpha
JNKc-Jun-N-terminal kinase
MAPKmitogen-activated protein kinases
MKK4mitogen-activated protein kinase kinase 4
NOXNADPH oxidase
NF-κBnuclear factor kappa-B
ADAlzheimer’s disease
AChEacetylcholine esterase
COX-2cyclooxygenase-2
MMP-8matrix metalloproteinase-8
CRMP-2collapsin response mediator protein-2
GSTglutathione S-transferase
GSH-Pxglutathione peroxidase
GRglutathione reductase
SODsuperoxide dismutase
CATcatalase
SAMP8senescence-accelerated mouse prone 8
PDParkinson’s disease
GSHglutathione
RPEretinal pigment epithelium
NLRP3NOD-like receptor protein 3
IL-1βinterleukin 1β
AP-1activator protein 1
MCP-1monocyte chemotactic protein 1
MDAmalondialdehyde
HO-1hemeoxygenase-1
TNF-αtumor necrosis factor-α
IFN-γinterferon-γ
ARaldose reductase
A2EN-retinylidene-N-retinylethanolamine
H9c2 cellsrat cardiomyocyte cell line
ALDH2aldehyde dehydrogenase 2
ox-LDLoxidized low-density lipoprotein
MMP-1matrix metalloproteinase-1
PPARαperoxisome proliferator-activated receptor α
AMPKAMP-activated protein kinase
AKR7A2Aldo-Keto reductase family 7 member A2
hAKR1B1human recombinant aldose reductase
PGC1peroxisome proliferator-activated receptor γ coactivator 1
IRS-1insulin receptor substrate-1
Aktprotein kinase B
PKAprotein kinase A
HSLhormone-sensitive lipase
HeLahuman cervical cancer
HMEChuman microvascular endothelial cells
HaCathuman keratinocytes
HOShuman osteosarcoma
LRP6lipoprotein receptor-related protein 6
MALDI-TOF/TOFmatrix-assisted laser desorption/ionization-tandem time of flight
LC-MS/MSliquid chromatography-tandem mass spectrometry

References

  1. Dalleau, S.; Baradat, M.; Guéraud, F.; Huc, L. Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 2013, 20, 1615–1630. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Breitzig, M.; Bhimineni, C.; Lockey, R.; Kolliputi, N. 4-Hydroxy-2-nonenal: A critical target in oxidative stress? Am. J. Physiol. Cell Physiol. 2016, 311, C537–C543. [Google Scholar] [CrossRef] [PubMed]
  3. Zarkovic, K.; Jakovcevic, A.; Zarkovic, N. Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases. Free Radic. Biol. Med. 2017, 111, 110–126. [Google Scholar] [CrossRef] [PubMed]
  4. Luczaj, W.; Gegotek, A.; Skrzydlewska, E. Antioxidants and HNE in redox homeostasis. Free Radic. Biol. Med. 2017, 111, 87–101. [Google Scholar] [CrossRef]
  5. Mali, V.R.; Palaniyandi, S.S. Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease. Free Radic. Res. 2014, 48, 251–263. [Google Scholar] [CrossRef]
  6. Cohen, G.; Riahi, Y.; Sunda, V.; Deplano, S.; Chatgilialoglu, C.; Ferreri, C.; Kaiser, N.; Sasson, S. Signaling properties of 4-hydroxyalkenals formed by lipid peroxidation in diabetes. Free Radic. Biol. Med. 2013, 65, 978–987. [Google Scholar] [CrossRef]
  7. Csala, M.; Kardon, T.; Legeza, B.; Lizák, B.; Mandl, J.; Margittai, É.; Puskás, F.; Száraz, P.; Szelényi, P.; Bánhegyi, G. On the role of 4-hydroxynonenal in health and disease. Biochim. Biophys. Acta 2015, 1852, 826–838. [Google Scholar] [CrossRef] [Green Version]
  8. Xiao, M.; Zhong, H.; Xia, L.; Tao, Y.; Yin, H. Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic. Biol. Med. 2017, 111, 316–327. [Google Scholar] [CrossRef]
  9. Rashid, S.; Ahmad, M.; Zafar, M.; Anwar, A.; Sultana, S.; Tabassum, S.; Ahmed, S.N. Ethnopharmacological evaluation and antioxidant activity of some important herbs used in traditional medicines. J. Tradit. Chin. Med. 2016, 36, 689–694. [Google Scholar] [CrossRef] [Green Version]
  10. Tresserra-Rimbau, A.; Lamuela-Raventos, R.M.; Moreno, J.J. Polyphenols, food and pharma. Current knowledge and directions for future research. Biochem. Pharmacol. 2018, 156, 186–195. [Google Scholar] [CrossRef]
  11. Olszowy, M. What is responsible for antioxidant properties of polyphenolic compounds from plants? Plant Physiol. Biochem. 2019, 144, 135–143. [Google Scholar] [CrossRef] [PubMed]
  12. Wang, Y.; Qi, W.; Huo, Y.; Song, G.; Sun, H.; Guo, X.; Wang, C. Cyanidin-3-glucoside attenuates 4-hydroxynonenal- and visible light-induced retinal damage in vitro and in vivo. Food Funct. 2019, 10, 2871–2880. [Google Scholar] [CrossRef] [PubMed]
  13. Jang, Y.J.; Kim, J.; Shim, J.; Kim, J.; Byun, S.; Oak, M.H.; Lee, K.W.; Lee, H.J. Kaempferol attenuates 4-hydroxynonenal-induced apoptosis in PC12 cells by directly inhibiting NADPH oxidase. J. Pharmacol. Exp. Ther. 2011, 337, 747–754. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Miller, D.M.; Singh, I.N.; Wang, J.A.; Hall, E.D. Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radic. Biol. Med. 2013, 57, 1–9. [Google Scholar] [CrossRef] [Green Version]
  15. Hortigon-Vinagre, M.P.; Blanco, J.; Ruiz, T.; Henao, F. Thymbra capitata essential oil prevents cell death induced by 4-hydroxy-2-nonenal in neonatal rat cardiac myocytes. Planta Med. 2014, 80, 1284–1290. [Google Scholar] [CrossRef]
  16. Liu, K.L.; Kuo, W.C.; Lin, C.Y.; Lii, C.K.; Liu, Y.L.; Cheng, Y.H.; Tsai, C.W. Prevention of 4-hydroxynonenal-induced lipolytic activation by carnosic acid is related to the induction of glutathione S-transferase in 3T3-L1 adipocytes. Free Radic. Biol. Med. 2018, 121, 1–8. [Google Scholar] [CrossRef]
  17. Neely, M.D.; Boutte, A.; Milatovic, D.; Montine, T.J. Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction. Brain Res. 2005, 1037, 90–98. [Google Scholar] [CrossRef]
  18. Caruana, M.; Cauchi, R.; Vassallo, N. Putative role of red wine polyphenols against brain pathology in Alzheimer’s and Parkinson’s disease. Front. Nutr. 2016, 3, 00031. [Google Scholar] [CrossRef] [Green Version]
  19. Jang, Y.J.; Kang, N.J.; Lee, K.W.; Lee, H.J. Protective effects of red wine flavonols on 4-hydroxynonenal-induced apoptosis in PC12 cells. Ann. N. Y. Acad. Sci. 2009, 1171, 170–175. [Google Scholar] [CrossRef]
  20. Elumalai, P.; Lakshmi, S. Role of quercetin benefits in neurodegeneration. Adv. Neurobiol. 2016, 12, 229–245. [Google Scholar]
  21. Joshi, V.; Mishra, R.; Upadhyay, A.; Amanullah, A.; PoluriK, M.; Singh, S.; Kumar, A.; Mishra, A. Polyphenolic flavonoid (Myricetin) upregulated proteasomal degradation mechanisms: Eliminates neurodegenerative proteins aggregation. J. Cell Physiol. 2019, 234, 20900–20914. [Google Scholar] [CrossRef] [PubMed]
  22. Wu, P.S.; Yen, J.H.; Kou, M.C.; Wu, M.J. Luteolin and apigenin attenuate 4-hydroxy-2-nonenal-mediated cell death through modulation of UPR, Nrf2-ARE and MAPK pathways in PC12 cells. PLoS ONE 2015, 10, e0130599. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Singhal, S.S.; Singh, S.P.; Singhal, P.; Horne, D.; Singhal, J.; Awasthi, S. Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling. Toxicol. Appl. Pharmacol. 2015, 289, 361–370. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Liu, W.; Kato, M.; Akhand, A.A.; Hayakawa, A.; Suzuki, H.; Miyata, T.; Kurokawa, K.; Hotta, Y.; Ishikawa, N.; Nakashima, I. 4-Hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J. Cell Sci. 2000, 113, 635–641. [Google Scholar] [PubMed]
  25. Jang, Y.J.; Kim, J.E.; Kang, N.J.; Lee, K.W.; Lee, H.J. Piceatannol attenuates 4-hydroxynonenal-induced apoptosis of PC12 cells by blocking activation of c-Jun N-terminal kinase. Ann. N. Y. Acad. Sci. 2009, 1171, 176–182. [Google Scholar] [CrossRef]
  26. Dumont, U.; Sanchez, S.; Olivier, B.; Chateil, J.F.; Pellerin, L.; Beauvieux, M.C.; Bouzier-Sore, A.K.; Roumes, H. Maternal consumption of piceatannol: A nutritional neuroprotective strategy against hypoxia-ischemia in rat neonate. Brain Res. 2019, 1717, 86–94. [Google Scholar] [CrossRef]
  27. Ye, Y.J.; Kim, Y.S.; Kang, M.S. Effects of citri reticulatae viride pericarpium on 4-hydroxynonenal-induced inflammation in PC12 cells. J. Korean Med. Obes. Res. 2016, 16, 79–84. [Google Scholar] [CrossRef] [Green Version]
  28. Cho, E.S.; Jang, Y.J.; Kang, N.J.; Hwang, M.K.; Kim, Y.T.; Lee, K.W.; Lee, H.J. Cocoa procyanidins attenuate 4-hydroxynonenal-induced apoptosis of PC12 cells by directly inhibiting mitogen-activated protein kinase kinase 4 activity. Free Radic. Biol. Med. 2009, 46, 1319–1327. [Google Scholar] [CrossRef]
  29. Nguyen, T.; Nioi, P.; Pickett, C.B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 2009, 284, 13291–13295. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Siddiqui, M.A.; Kashyap, M.P.; Kumar, V.; Al-Khedhairy, A.A.; Musarrat, J.; Pant, A.B. Protective potential of trans-resveratrol against 4-hydroxynonenal induced damage in PC12 cells. Toxicol. In Vitro 2010, 24, 1592–1598. [Google Scholar] [CrossRef] [PubMed]
  31. Hernandes, M.S.; D’Avila, J.C.; Trevelin, S.C.; Reis, P.A.; Kinjo, E.R.; Lopes, L.R.; Castro-Faria-Neto, H.C.; Cunha, F.Q.; Britto, L.R.; Bozza, F.A. The role of Nox2-derived ROS in the development of cognitive impairment after sepsis. J. Neuroinflamm. 2014, 11, 36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Sun, J.B.; Li, Y.; Cai, Y.F.; Huang, Y.; Liu, S.; Yeung, P.K.; Deng, M.Z.; Sun, G.S.; Zilundu, P.L.; Hu, Q.S.; et al. Scutellarin protects oxygen/glucose-deprived astrocytes and reduces focal cerebral ischemic injury. Neural Regen. Res. 2018, 13, 1396–1407. [Google Scholar] [PubMed]
  33. Di Domenico, F.; Tramutola, A.; Butterfield, D.A. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders. Free Radic. Biol. Med. 2017, 111, 253–261. [Google Scholar] [CrossRef] [PubMed]
  34. Benedetti, E.; D’Angelo, B.; Cristiano, L.; Di Giacomo, E.; Fanelli, F.; Moreno, S.; Cecconi, F.; Fidoamore, A.; Antonosante, A.; Falcone, R.; et al. Involvement of peroxisome proliferator-activated receptor β/δ (PPAR β/δ) in BDNF signaling during aging and in Alzheimer disease: Possible role of 4-hydroxynonenal (4-HNE). Cell Cycle 2014, 13, 1335–1344. [Google Scholar] [CrossRef]
  35. Rasool, M.; Malik, A.; Waquar, S.; Tul-Ain, Q.; Jafar, T.H.; Rasool, R.; Kalsoom, A.; Ghafoor, M.A.; Sehgal, S.A.; Gauthaman, K.; et al. In-Silico characterization and in-vivo validation of albiziasaponin-A, iso-orientin, and salvadorin using a rat model of Alzheimer’s disease. Front. Pharmacol. 2018, 9, 730. [Google Scholar] [CrossRef]
  36. Curtis, J.M.; Grimsrud, P.A.; Wright, W.S.; Xu, X.; Foncea, R.E.; Graham, D.W.; Brestoff, J.R.; Wiczer, B.M.; Ilkayeva, O.; Cianflone, K.; et al. Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes 2010, 59, 1132–1142. [Google Scholar] [CrossRef] [Green Version]
  37. Ghofrani, S.; Joghataei, M.T.; Mohseni, S.; Baluchnejadmojarad, T.; Bagheri, M.; Khamse, S.; Roghani, M. Naringenin improves learning and memory in an Alzheimer’s disease rat model: Insights into the underlying mechanisms. Eur. J. Pharmacol. 2015, 764, 195–201. [Google Scholar] [CrossRef] [Green Version]
  38. Khan, M.B.; Khan, M.M.; Khan, A.; Ahmed, M.E.; Ishrat, T.; Tabassum, R.; Vaibhav, K.; Ahmad, A.; Islam, F. Naringenin ameliorates Alzheimer’s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model. Neurochem. Int. 2012, 61, 1081–1093. [Google Scholar] [CrossRef]
  39. Lawal, M.F.; Olotu, F.A.; Agoni, C.; Soliman, M.E. Exploring the C-terminal tail dynamics: Structural and molecular perspectives into the therapeutic activities of novel CRMP-2 inhibitors, naringenin and naringenin-7-O-glucuronide, in the treatment of Alzheimer’s disease. Chem. Biodivers. 2018, 15, e1800437. [Google Scholar] [CrossRef]
  40. Lawal, M.; Olotu, F.A.; Soliman, M.E.S. Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer’s disease using bioinformatics and computational tools. Comput. Biol. Med. 2018, 98, 168–177. [Google Scholar] [CrossRef]
  41. Farr, S.A.; Niehoff, M.L.; Ceddia, M.A.; Herrlinger, K.A.; Lewis, B.J.; Feng, S.L.; Welleford, A.; Butterfield, D.A.; Morley, J.E. Effect of botanical extracts containing carnosic acid or rosmarinic acid on learning and memory in SAMP8 mice. Physiol. Behav. 2016, 165, 328–338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Kantar Gok, D.; Hidisoglu, E.; Ocak, G.A.; Er, H.; Acun, A.D.; Yargıcoglu, P. Protective role of rosmarinic acid on amyloid beta 42-induced echoic memory decline: Implication of oxidative stress and cholinergic impairment. Neurochem. Int. 2018, 118, 1–13. [Google Scholar] [CrossRef] [PubMed]
  43. Cai, S.; Yang, H.; Wen, B.; Zhu, K.; Zheng, X.; Huang, J.; Wang, Y.; Liu, Z.; Tu, P. Inhibition by microbial metabolites of Chinese dark tea of age-related neurodegenerative disorders in senescence-accelerated mouse prone 8 (SAMP8) mice. Food Funct. 2018, 9, 5455–5462. [Google Scholar] [CrossRef] [PubMed]
  44. Goes, A.T.R.; Jesse, C.R.; Antunes, M.S.; Lobo Ladd, F.V.; Lobo Ladd, A.A.B.; Luchese, C.; Paroul, N.; Boeira, S.P. Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson’s disease: Involvement of neuroinflammation and neurotrophins. Chem. Biol. Interact. 2018, 279, 111–120. [Google Scholar] [CrossRef] [PubMed]
  45. Lv, C.; Hong, T.; Yang, Z.; Zhang, Y.; Wang, L.; Dong, M.; Zhao, J.; Mu, J.; Meng, Y. Effect of quercetin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse model of Parkinson’s disease. Evid. Based Complement. Alternat. Med. 2012, 2012, 928643. [Google Scholar] [CrossRef]
  46. Deng, R.; Hua, X.; Li, J.; Chi, W.; Zhang, Z.; Lu, F.; Zhang, L.; Pflugfelder, S.C.; Li, D.Q. Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells. PLoS ONE 2015, 10, e0126561. [Google Scholar] [CrossRef] [Green Version]
  47. Seen, S.; Tong, L. Dry eye disease and oxidative stress. Acta Ophthalmol. 2018, 96, E412–E420. [Google Scholar] [CrossRef] [Green Version]
  48. Raman, T.; Ramar, M.; Arumugam, M.; Nabavi, S.M.; Varsha, M.K. Cytoprotective mechanism of action of curcumin against cataract. Pharmacol. Rep. 2016, 68, 561–569. [Google Scholar] [CrossRef]
  49. Chen, J.; Wang, L.; Chen, Y.; Sternberg, P.; Cai, J. Phosphatidylinositol 3 kinase pathway and 4-hydroxy-2-nonenal-induced oxidative injury in the RPE. Investig. Ophthalmol. Vis. Sci. 2009, 50, 936–942. [Google Scholar] [CrossRef]
  50. Vatsyayan, R.; Chaudhary, P.; Sharma, A.; Sharma, R.; Rao Lelsani, P.C.; Awasthi, S.; Awasthi, Y.C. Role of 4-hydroxynonenal in epidermal growth factor receptor-mediated signaling in retinal pigment epithelial cells. Exp. Eye Res. 2011, 92, 147–154. [Google Scholar] [CrossRef] [Green Version]
  51. Choi, W.; Lee, J.B.; Cui, L.; Li, Y.; Li, Z.R.; Choi, J.S.; Lee, H.S.; Yoon, K.C. Therapeutic efficacy of topically applied antioxidant medicinal plant extracts in a mouse model of experimental dry eye. Oxid. Med. Cell Longev. 2016, 2016, 4727415. [Google Scholar] [CrossRef] [PubMed]
  52. Chang, K.C.; Shieh, B.; Petrash, J.M. Role of aldose reductase in diabetes-induced retinal microglia activation. Chem. Biol. Interact. 2019, 302, 46–52. [Google Scholar] [CrossRef] [PubMed]
  53. Lu, Q.; Hao, M.; Wu, W.Y.; Zhang, N.; Isaac, A.T.; Yin, J.L.; Zhu, X.; Du, L.; Yin, X.X. Antidiabetic cataract effects of GbE, rutin and quercetin are mediated by the inhibition of oxidative stress and polyol pathway. Acta Biochim. Pol. 2018, 65, 35–41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Feng, X.; Sureda, A.; Jafari, S.; Memariani, Z.; Tewari, D.; Annunziata, G.; Barrea, L.; Hassan, S.T.S.; Smejkal, K.; Malanik, M.; et al. Berberine in cardiovascular and metabolic diseases: From mechanisms to therapeutics. Theranostics 2019, 9, 1923–1951. [Google Scholar] [CrossRef]
  55. Yang, S.H.; Wu, M.Y.; Fu, D.X.; Chen, J.P.; Zhang, J.; Wilson, K.; Elliot, M.; Du, M.; Lyo, T. Berberine acts as a novel autophagy blocker to protect human müLler cell from 4-hne induced cell death. Investig. Ophthalmol. Vis. Sci. 2012, 53, 2019. [Google Scholar]
  56. Yu, C.C.; Nandrot, E.F.; Dun, Y.; Finnemann, S.C. Dietary antioxidants prevent age-related retinal pigment epithelium actin damage and blindness in mice lacking alpha v beta 5 integrin. Free Radic. Biol. Med. 2012, 52, 660–670. [Google Scholar] [CrossRef] [Green Version]
  57. Xu, D.; Hu, M.J.; Wang, Y.Q.; Cui, Y.L. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules 2019, 24, 1123. [Google Scholar] [CrossRef] [Green Version]
  58. Hytti, M.; Piippo, N.; Salminen, A.; Honkakoski, P.; Kaarniranta, K.; Kauppinen, A. Quercetin alleviates 4-hydroxynonenal-induced cytotoxicity and inflammation in ARPE-19 cells. Exp. Eye Res. 2015, 132, 208–215. [Google Scholar] [CrossRef]
  59. Shao, Y.; Yu, H.; Yang, Y.; Li, M.; Hang, L.; Xu, X. A solid dispersion of quercetin shows enhanced Nrf2 activation and protective effects against oxidative injury in a mouse model of dry age-related macular degeneration. Oxid. Med. Cell. Longev. 2019, 2019, 1479571. [Google Scholar] [CrossRef]
  60. Wang, Y.; Kim, H.J.; Sparrow, J.R. Quercetin and cyanidin-3-glucoside protect against photooxidation and photodegradation of A2E in retinal pigment epithelial cells. Exp. Eye Res. 2017, 160, 45–55. [Google Scholar] [CrossRef]
  61. Yu, M.Z.; Yan, W.M.; Beight, C. Lutein and zeaxanthin isomers protect against light-induced retinopathy via decreasing oxidative and endoplasmic reticulum stress in BALB/cJ mice. Nutrients 2018, 10, 842. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Tseng, W.A.; Thein, T.; Kinnunen, K.; Lashkari, K.; Gregory, M.S.; D’Amore, P.A.; Ksander, B.R. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: Implications for age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2013, 54, 110–120. [Google Scholar] [CrossRef] [PubMed]
  63. Wang, Y.; Huo, Y.Z.; Zhao, L.; Lu, F.; Wang, O.; Yang, X.; Ji, B.P.; Zhou, F. Cyanidin-3-glucoside and its phenolic acid metabolites attenuate visible light-induced retinal degeneration in vivo via activation of Nrf2/HO-1 pathway and NF-κB suppression. Mol. Nutr. Food Res. 2016, 60, 1564–1577. [Google Scholar] [CrossRef] [PubMed]
  64. Jin, X.L.; Wang, C.T.; Wu, W.; Liu, T.T.; Ji, B.P.; Zhou, F. Cyanidin-3-glucoside alleviates 4-hydroxyhexenal-induced NLRP3 inflammasome activation via JNK-c-Jun/AP-1 pathway in human retinal pigment epithelial cells. J. Immunol. Res. 2018, 2018, 5604610. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Cheng, S.C.; Huang, W.C.; JH, S.P.; Wu, Y.H.; Cheng, C.Y. Quercetin inhibits the production of IL-1beta-induced inflammatory cytokines and chemokines in ARPE-19 cells via the MAPK and NF-kappaB signaling pathways. Int. J. Mol. Sci. 2019, 20, 2957. [Google Scholar] [CrossRef] [Green Version]
  66. Chapple, S.J.; Cheng, X.; Mann, G.E. Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease. Redox Biol. 2013, 1, 319–331. [Google Scholar] [CrossRef] [Green Version]
  67. Phaniendra, A.; Jestadi, D.B.; Periyasamy, L. Free radicals: Properties, sources, targets, and their implication in various diseases. Indian J. Clin. Biochem. 2015, 30, 11–26. [Google Scholar] [CrossRef] [Green Version]
  68. Bali, E.B.; Ergin, V.; Rackova, L.; Bayraktar, O.; Kucukboyaci, N.; Karasu, C. Olive leaf extracts protect cardiomyocytes against 4-hydroxynonenal-induced toxicity in vitro: Comparison with oleuropein, hydroxytyrosol, and quercetin. Planta Med. 2014, 80, 984–992. [Google Scholar] [CrossRef] [Green Version]
  69. Othman, A.I.; El-Sawi, M.R.; El-Missiry, M.A.; Abukhalil, M.H. Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats. Biomed. Pharmacother. 2017, 94, 362–373. [Google Scholar] [CrossRef]
  70. Xin, Y.; Bai, Y.; Jiang, X.; Zhou, S.; Wang, Y.; Wintergerst, K.A.; Cui, T.; Ji, H.; Tan, Y.; Cai, L. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway. Redox Biol. 2018, 15, 405–417. [Google Scholar] [CrossRef]
  71. Liu, B.; Zhao, C.; Li, H.; Chen, X.; Ding, Y.; Xu, S. Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis. Biochem. Biophys. Res. Commun. 2018, 497, 233–240. [Google Scholar] [CrossRef] [PubMed]
  72. He, L.; Liu, B.; Dai, Z.; Zhang, H.F.; Zhang, Y.S.; Luo, X.J.; Ma, Q.L.; Peng, J. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. Eur. J. Pharmacol. 2012, 678, 32–328. [Google Scholar] [CrossRef] [PubMed]
  73. Kurumazuka, D.; Kitada, K.; Tanaka, R.; Mori, T.; Ohkita, M.; Takaoka, M.; Matsumura, Y. α-Lipoic acid exerts a primary prevention for the cardiac dysfunction in aortocaval fistula-created rat hearts. Heliyon 2019, 5, e02371. [Google Scholar] [CrossRef] [PubMed]
  74. Jiang, W.B.; Zhao, W.; Chen, H.; Wu, Y.Y.; Wang, Y.; Fu, G.S.; Yang, X.J. Baicalin protects H9c2 cardiomyocytes against hypoxia/reoxygenation-induced apoptosis and oxidative stress through activation of mitochondrial aldehyde dehydrogenase 2. Clin. Exp. Pharmacol. Physiol. 2018, 45, 303–311. [Google Scholar] [CrossRef] [PubMed]
  75. Negre-Salvayre, A.; Garoby-Salom, S.; Swiader, A.; Rouahi, M.; Pucelle, M.; Salvayre, R. Proatherogenic effects of 4-hydroxynonenal. Free Radic. Biol. Med. 2017, 111, 127–139. [Google Scholar] [CrossRef]
  76. Akiba, S.; Yamaguchi, H.; Kumazawa, S.; Oka, M.; Sato, T. Suppression of oxidized LDL-induced PDGF receptor beta activation by Ginkgo biloba extract reduces MMP-1 production in coronary smooth muscle cells. J. Atheroscler. Thromb. 2007, 14, 219–225. [Google Scholar] [CrossRef] [Green Version]
  77. Keller, J.; Camaré, C.; Bernis, C.; Astello-García, M.; de la Rosa, A.P.; Rossignol, M.; del Socorro Santos Díaz, M.; Salvayre, R.; Negre-Salvayre, A.; Guéraud, F. Antiatherogenic and antitumoral properties of Opuntia cladodes: Inhibition of low density lipoprotein oxidation by vascular cells, and protection against the cytotoxicity of lipid oxidation product 4-hydroxynonenal in a colorectal cancer cellular model. J. Physiol. Biochem. 2015, 71, 577–587. [Google Scholar] [CrossRef]
  78. Garoby-Salom, S.; Guéraud, F.; Camaré, C.; de la Rosa, A.P.; Rossignol, M.; Santos Díaz Mdel, S.; Salvayre, R.; Negre-Salvayre, A. Dietary cladode powder from wild type and domesticated Opuntia species reduces atherogenesis in apoE knock-out mice. J. Physiol. Biochem. 2016, 72, 59–70. [Google Scholar] [CrossRef]
  79. Shearn, C.T.; Reigan, P.; Petersen, D.R. Inhibition of hydrogen peroxide signaling by 4-hydroxynonenal due to differential regulation of Akt1 and Akt2 contributes to decreases in cell survival and proliferation in hepatocellular carcinoma cells. Free Radic. Biol. Med. 2012, 53, 1–11. [Google Scholar] [CrossRef] [Green Version]
  80. Seo, B.Y.; Choi, M.J.; Kim, J.S.; Park, E. Comparative analysis of ginsenoside profiles: Antioxidant, antiproliferative, and antigenotoxic activities of Ginseng extracts of gine and main roots. Prev. Nutr. Food Sci. 2019, 24, 128–135. [Google Scholar] [CrossRef]
  81. Kim, H.G.; Jang, S.S.; Lee, J.S.; Kim, H.S.; Son, C.G. Panax ginseng Meyer prevents radiation-induced liver injury via modulation of oxidative stress and apoptosis. J. Ginseng Res. 2017, 41, 159–168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Han, J.Y.; Lee, S.; Yang, J.H.; Kim, S.; Sim, J.; Kim, M.G.; Jeong, T.C.; Ku, S.K.; Cho, I.J.; Ki, S.H. Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK/Sirt1 activation. J. Ginseng Res. 2015, 39, 105–115. [Google Scholar] [CrossRef] [Green Version]
  83. Choudhry, Q.N.; Kim, J.H.; Cho, H.T.; Heo, W.; Lee, J.J.; Lee, J.H.; Kim, Y.J. Ameliorative effect of black ginseng extract against oxidative stress-induced cellular damages in mouse hepatocytes. J. Ginseng Res. 2019, 43, 179–185. [Google Scholar] [CrossRef] [PubMed]
  84. Xu, X.Y.; Wang, Z.; Ren, S.; Leng, J.; Hu, J.N.; Liu, Z.; Chen, C.; Li, W. Improved protective effects of American ginseng berry against acetaminophen-induced liver toxicity through TNF-α-mediated caspase-3/-8/-9 signaling pathways. Phytomedicine 2018, 51, 128–138. [Google Scholar] [CrossRef] [PubMed]
  85. Qian, Q.Y.; Ying, N.; Yang, Z.; Zhou, L.; Liu, Q.S.; Hu, Z.Y.; Fan, C.L.; Li, S.T.; Dou, X.B. Mechanisms of tanshinone Ⅱ_A in reducing 4-HNE-induced hepatocyte damage by activating PPARα. Zhongguo Zhong Yao Za Zhi 2019, 44, 1862–1868. (In Chinese) [Google Scholar]
  86. Sundarraj, K.; Raghunath, A.; Perumal, E. A review on the chemotherapeutic potential of fisetin: In vitro evidences. Biomed. Pharmacother. 2018, 97, 928–940. [Google Scholar] [CrossRef]
  87. Yousefzadeh, M.J.; Zhu, Y.; McGowan, S.J.; Angelini, L.; Fuhrmann-Stroissnigg, H.; Xu, M.; Ling, Y.Y.; Melos, K.I.; Pirtskhalava, T.; Inman, C.L.; et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 2018, 36, 18–28. [Google Scholar] [CrossRef] [Green Version]
  88. Cha, H.; Lee, S.; Lee, J.H.; Park, J.W. Protective effects of p-coumaric acid against acetaminophen-induced hepatotoxicity in mice. Food Chem. Toxicol. 2018, 121, 131–139. [Google Scholar] [CrossRef]
  89. Seo, H.L.; Baek, S.Y.; Lee, E.H.; Lee, J.H.; Lee, S.G.; Kim, K.Y.; Jang, M.H.; Park, M.H.; Kim, J.H.; Kim, K.J.; et al. Liqustri lucidi Fructus inhibits hepatic injury and functions as an antioxidant by activation of AMP-activated protein kinase in vivo and in vitro. Chem. Biol. Interact. 2017, 262, 57–68. [Google Scholar] [CrossRef]
  90. Li, D.; Gu, Z.; Zhang, J.; Ma, S. Protective effect of inducible aldo-keto reductases on 4-hydroxynonenal-induced hepatotoxicity. Chem. Biol. Interact. 2019, 304, 124–130. [Google Scholar] [CrossRef]
  91. Balestri, F.; De Leo, M.; Sorce, C.; Cappiello, M.; Quattrini, L.; Moschini, R.; Pineschi, C.; Braca, A.; La Motta, C.; Da Settimo, F.; et al. Soyasaponins from Zolfino bean as aldose reductase differential inhibitors. J. Enzyme Inhib. Med. Chem. 2019, 34, 350–360. [Google Scholar] [CrossRef] [PubMed]
  92. Elrayess, M.A.; Almuraikhy, S.; Kafienah, W.; Al Menhali, A.; Al-Khelaifi, F.; Bashah, M.; Zarkovic, K.; Zarkovic, N.; Waeg, G.; Alsayrafi, M.; et al. 4-Hydroxynonenal causes impairment of human subcutaneous adipogenesis and induction of adipocyte insulin resistance. Free Radic. Biol. Med. 2017, 104, 129–137. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Pillon, N.J.; Croze, M.L.; Vella, R.E.; Soulere, L.; Lagarde, M.; Soulage, C.O. The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress. Endocrinology 2012, 153, 2099–2111. [Google Scholar] [CrossRef] [PubMed]
  94. Wang, Z.; Dou, X.; Gu, D.; Shen, C.; Yao, T.; Nguyen, V.; Braunschweig, C.; Song, Z. 4-Hydroxynonenal differentially regulates adiponectin gene expression and secretion via activating PPARgamma and accelerating ubiquitin-proteasome degradation. Mol. Cell Endocrinol. 2012, 349, 222–231. [Google Scholar] [CrossRef] [Green Version]
  95. Killion, E.A.; Reeves, A.R.; El Azzouny, M.A.; Yan, Q.W.; Surujon, D.; Griffin, J.D.; Bowman, T.A.; Wang, C.; Matthan, N.R.; Klett, E.L.; et al. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction. Mol. Metab. 2018, 9, 43–56. [Google Scholar] [CrossRef]
  96. Guo, L.; Zhang, X.M.; Zhang, Y.B.; Huang, X.; Chi, M.H. Association of 4-hydroxynonenal with classical adipokines and insulin resistance in a Chinese non-diabetic obese population. Nutr. Hosp. 2017, 34, 363–368. [Google Scholar] [CrossRef]
  97. Lee, H.; Lim, Y. Tocotrienol-rich fraction supplementation reduces hyperglycemia-induced skeletal muscle damage through regulation of insulin signaling and oxidative stress in type 2 diabetic mice. J. Nutr. Biochem. 2018, 57, 77–85. [Google Scholar] [CrossRef]
  98. Mahboubi, M. Morus alba (mulberry), a natural potent compound in management of obesity. Pharmacol. Res. 2019, 146, 104341. [Google Scholar] [CrossRef]
  99. Kavitha, Y.; Geetha, A. Anti-inflammatory and preventive activity of white mulberry root bark extract in an experimental model of pancreatitis. J. Tradit. Complement. Med. 2018, 8, 497–505. [Google Scholar] [CrossRef]
  100. Adisakwattana, S.; Intrawangso, J.; Hemrid, A.; Chanathong, B.; Makynen, K. Extracts of edible plants inhibit pancreatic lipase, cholesterol esterase and cholesterol micellization, and bind bile acids. Food Technol. Biotechnol. 2012, 50, 11–16. [Google Scholar]
  101. Ann, J.Y.; Eo, H.; Lim, Y. Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice. Genes Nutr. 2015, 10, 46. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Singh, C.K.; Kumar, A.; Lavoie, H.A.; Dipette, D.J.; Singh, U.S. Diabetic complications in pregnancy: Is resveratrol a solution? Exp. Biol. Med. 2013, 238, 482–490. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Al-Hussaini, H.; Kilarkaje, N. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys. Toxicol. Appl. Pharmacol. 2018, 339, 97–109. [Google Scholar] [CrossRef]
  104. Sukumar, P.; Viswambharan, H.; Imrie, H.; Cubbon, R.M.; Yuldasheva, N.; Gage, M.; Galloway, S.; Skromna, A.; Kandavelu, P.; Santos, C.X.; et al. Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction. Diabetes 2013, 62, 2130–2134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Mahmoud, A.M.; Ali, M.M.; Miranda, E.R.; Mey, J.T.; Blackburn, B.K.; Haus, J.M.; Phillips, S.A. Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function. Redox Biol. 2017, 13, 288–300. [Google Scholar] [CrossRef] [PubMed]
  106. Cremonini, E.; Wang, Z.; Bettaieb, A.; Adamo, A.M.; Daveri, E.; Mills, D.A.; Kalanetra, K.M.; Haj, F.G.; Karakas, S.; Oteiza, P.I. (−)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: Implications for steatosis and insulin resistance. Redox Biol. 2018, 14, 588–599. [Google Scholar] [CrossRef] [PubMed]
  107. Daveri, E.; Cremonini, E.; Mastaloudis, A.; Hester, S.N.; Wood, S.M.; Waterhouse, A.L.; Anderson, M.; Fraga, C.G.; Oteiza, P.I. Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice. Redox Biol. 2018, 18, 16–24. [Google Scholar] [CrossRef] [PubMed]
  108. Yang, B.Y.; Guo, Y.; Markevych, I.; Qian, Z.M.; Bloom, M.S.; Heinrich, J.; Dharmage, S.C.; Rolling, C.A.; Jordan, S.S.; Komppula, M.; et al. Association of long-term exposure to ambient air pollutants with risk factors for cardiovascular disease in China. JAMA Netw. Open 2019, 2, e190318. [Google Scholar] [CrossRef] [Green Version]
  109. De Bont, J.; Casas, M.; Barrera-Gomez, J.; Cirach, M.; Rivas, I.; Valvi, D.; Alvarez, M.; Dadvand, P.; Sunyer, J.; Vrijheid, M. Ambient air pollution and overweight and obesity in school-aged children in Barcelona, Spain. Environ. Int. 2019, 125, 58–64. [Google Scholar] [CrossRef]
  110. Lucht, S.; Hennig, F.; Moebus, S.; Fuhrer-Sakel, D.; Herder, C.; Jockel, K.H.; Hoffmann, B.; Heinz, G. Air pollution and diabetes-related biomarkers in non-diabetic adults: A pathway to impaired glucose metabolism? Environ. Int. 2019, 124, 370–392. [Google Scholar] [CrossRef]
  111. Wang, N.; Ma, Y.; Liu, Z.; Liu, L.; Yang, K.; Wei, Y.; Liu, Y.; Chen, X.; Sun, X. and Wen, D. Hydroxytyrosol prevents PM2.5-induced adiposity and insulin resistance by restraining oxidative stress related NF-kappaB pathway and modulation of gut microbiota in a murine model. Free Radic. Biol. Med. 2019, 141, 393–407. [Google Scholar] [CrossRef]
  112. Gallo, G.; Bruno, R.; Taranto, A.; Martino, G. Are polyunsaturated fatty acid metabolites, the protective effect of 4-hydroxytyrosol on human red blood cell membranes and oxidative damage (4-hydroxyalkenals) compatible in hypertriglyceridemic patients? Pharmacogn. Mag. 2017, 13, S561–S566. [Google Scholar] [CrossRef] [PubMed]
  113. Cesar, V.; Jozić, I.; Begović, L.; Vuković, T.; Mlinarić, S.; Lepeduš, H.; Borović Šunjić, S.; Žarković, N. Cell-type-specific modulation of hydrogen peroxide cytotoxicity and 4-hydroxynonenal binding to human cellular proteins in vitro by antioxidant Aloe vera extract. Antioxidants 2018, 7, 125. [Google Scholar] [CrossRef] [Green Version]
  114. Cheng, P.; Kuang, F.; Ju, G. Aescin reduces oxidative stress and provides neuroprotection in experimental traumatic spinal cord injury. Free Radic. Biol. Med. 2016, 99, 405–417. [Google Scholar] [CrossRef] [PubMed]
  115. Sirtori, C.R. Aescin: Pharmacology, pharmacokinetics and therapeutic profile. Pharmacol. Res. 2001, 44, 183–193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  116. Li, Q.; Lin, F.Q.; Wang, S.Q.; Hong, W.S.; Xu, A. Protective capacity of five kinds of plant extracts on 4HNE-induced melanocyte. Chin. Arch. Tradit. Chin. Med. 2015, 33, 1610–1613. [Google Scholar]
  117. Gegotek, A.; Bielawska, K.; Biernacki, M.; Dobrzynska, I.; Skrzydlewska, E. Time-dependent effect of rutin on skin fibroblasts membrane disruption following UV radiation. Redox Biol. 2017, 12, 733–744. [Google Scholar] [CrossRef]
  118. Gegotek, A.; Bielawska, K.; Biernacki, M.; Zareba, I.; Surazynski, A.; Skrzydlewska, E. Comparison of protective effect of ascorbic acid on redox and endocannabinoid systems interactions in in vitro cultured human skin fibroblasts exposed to UV radiation and hydrogen peroxide. Arch. Dermatol. Res. 2017, 309, 285–303. [Google Scholar] [CrossRef] [Green Version]
  119. Yamaguchi, T.; Yoneyama, M.; Hinoi, E.; Ogita, K. Involvement of calpain in 4-hydroxynonenal-induced disruption of gap junction-mediated intercellular communication among fibrocytes in primary cultures derived from the cochlear spiral ligament. J. Pharmacol. Sci. 2015, 129, 127–134. [Google Scholar] [CrossRef] [Green Version]
  120. Castaneda, R.; Natarajan, S.; Jeong, S.Y.; Hong, B.N.; Kang, T.H. Traditional oriental medicine for sensorineural hearing loss: Can ethnopharmacology contribute to potential drug discovery? J. Ethnopharmacol. 2018, 231, 409–428. [Google Scholar] [CrossRef]
  121. Xiong, M.; He, Q.L.; Lai, H.W.; Wang, J. Astragaloside IV inhibits apoptotic cell death in the guinea pig cochlea exposed to impulse noise. Acta Otolaryngol. 2012, 132, 467–474. [Google Scholar] [CrossRef] [PubMed]
  122. Xiong, M.; Lai, H.; He, Q.; Wang, J. Astragaloside IV attenuates impulse noise-induced trauma in guinea pig. Acta Otolaryngol. 2011, 131, 809–816. [Google Scholar] [CrossRef] [PubMed]
  123. Fetoni, A.R.; Paciello, F.; Rolesi, R.; Eramo, S.L.M.; Mancuso, C.; Troiani, D.; Paludetti, G. Rosmarinic acid up-regulates the noise-activated Nrf2/HO-1 pathway and protects against noise-induced injury in rat cochlea. Free Radic. Biol. Med. 2015, 85, 269–281. [Google Scholar] [CrossRef] [PubMed]
  124. Kanner, J.; Selhub, J.; Shpaizer, A.; Rabkin, B.; Shacham, I.; Tirosh, O. Redox homeostasis in stomach medium by foods: The Postprandial Oxidative Stress Index (POSI) for balancing nutrition and human health. Redox Biol. 2017, 12, 929–936. [Google Scholar] [CrossRef]
  125. Lamothe, S.; Guérette, C.; Dion, F.; Sabik, H.; Britten, M. Antioxidant activity of milk and polyphenol-rich beverages during simulated gastrointestinal digestion of linseed oil emulsions. Food Res. Int. 2019, 122, 149–156. [Google Scholar] [CrossRef]
  126. Tullberg, C.; Vegarud, G.; Undeland, I. Oxidation of marine oils during in vitro gastrointestinal digestion with human digestive fluids – Role of oil origin, added tocopherols and lipolytic activity. Food Chem. 2019, 270, 527–537. [Google Scholar] [CrossRef]
  127. Pasko, P.; Barton, H.; Zagrodzki, P.; Izewska, A.; Krosniak, M.; Gawlik, M.; Gawlik, M.; Gorinstein, S. Effect of amaranth seeds in diet on oxidative status in plasma and selected tissues of high fructose-fed rats. Plant. Foods Hum. Nutr. 2010, 65, 146–151. [Google Scholar] [CrossRef]
  128. Cherkas, A.; Zarkovic, K.; Cipak Gasparovic, A.; Jaganjac, M.; Milkovic, L.; Abrahamovych, O.; Yatskevych, O.; Waeg, G.; Yelisyeyeva, O.; Zarkovic, N. Amaranth oil reduces accumulation of 4-hydroxynonenal-histidine adducts in gastric mucosa and improves heart rate variability in duodenal peptic ulcer patients undergoing Helicobacter pylori eradication. Free Radic. Res. 2018, 52, 135–149. [Google Scholar] [CrossRef]
  129. Boyd, O.; Weng, P.; Sun, X.P.; Alberico, T.; Laslo, M.; Obenland, D.M.; Kern, B.; Zou, S. Nectarine promotes longevity in Drosophila melanogaster. Free Radic. Biol. Med. 2011, 50, 1669–1678. [Google Scholar] [CrossRef] [Green Version]
  130. Zheng, R.J.; Dragomir, A.C.; Mishin, V.; Richardson, J.R.; Heck, D.E.; Laskin, D.L.; Laskin, J.D. Differential metabolism of 4-hydroxynonenal in liver, lung and brain of mice and rats. Toxicol. Appl. Pharm. 2014, 279, 43–52. [Google Scholar] [CrossRef] [Green Version]
  131. Huang, Y.; Li, W.; Kong, A.N. Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal. Cell Biosci. 2012, 2, 40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  132. Gross, B.; Pawlak, M.; Lefebvre, P.; Staels, B. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat. Rev. Endocrinol. 2017, 13, 36–49. [Google Scholar] [CrossRef] [PubMed]
  133. Cheng, R.; Ding, L.X.; He, X.M.; Takahashi, Y.; Ma, J.X. Interaction of PPAR alpha with the canonic Wnt pathway in the regulation of renal fibrosis. Diabetes 2016, 65, 3730–3743. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  134. Hosoi, T.; Kuwamura, A.; Thon, M.; Tsuchio, K.; Abd El-Hafeez, A.A.; Ozawa, K. Possible involvement of 4-hydroxy-2-nonenal in the pathogenesis of leptin resistance in obesity. Am. J. Physiol. Cell Physiol. 2019, 316, C641–C648. [Google Scholar] [CrossRef]
  135. Aslebagh, R.; Pfeffer, B.A.; Fliesler, S.J.; Darie, C.C. Mass spectrometry-based proteomics of oxidative stress: Identification of 4-hydroxy-2-nonenal (HNE) adducts of amino acids using lysozyme and bovine serum albumin as model proteins. Electrophoresis 2016, 37, 2615–2623. [Google Scholar] [CrossRef] [Green Version]
  136. Mendez, D.; Hernaez, M.L.; Diez, A.; Puyet, A.; Bautista, J.M. Combined proteomic approaches for the identification of specific amino acid residues modified by 4-hydroxy-2-nonenal under physiological conditions. J. Protome. Res. 2010, 9, 5770–5781. [Google Scholar] [CrossRef]
  137. Delosiere, M.; Sante-Lhoutellier, V.; Chantelauze, C.; Durand, D.; Thomas, A.; Joly, C.; Pujos-Guillot, E.; Remond, D.; Comte, B.; Gladine, C.; et al. Quantification of 4-hydroxy-2-nonenal-protein adducts in the in vivo gastric digesta of mini-pigs using a GC-MS/MS method with accuracy profile validation. Food Funct. 2016, 7, 3497–3504. [Google Scholar] [CrossRef]
  138. Colzani, M.; Criscuolo, A.; De Maddis, D.; Garzon, D.; Yeum, K.J.; Vistoli, G.; Carini, M.; Aldini, G. A novel high resolution MS approach for the screening of 4-hydroxy-trans-2-nonenal sequestering agents. J. Pharmaceut. Biomed. 2014, 91, 108–118. [Google Scholar] [CrossRef]
Table 1. Medicinal plants and bioactive compounds in the attenuation of 4-HNE-induced deleterious effects.
Table 1. Medicinal plants and bioactive compounds in the attenuation of 4-HNE-induced deleterious effects.
Medicinal Plants and Bioactive CompoundsAction/Mechanism4-HNE-Induced ModelReferences
Neuroprotection
Polyphenol extract
(red wine)
Inhibition of cleavage of PARP, reduction of ROS, protection against apoptosisPC12 cells with apoptosis[19]
Quercetin
Myricetin
(red wine extract or G. biloba)
Cytoprotective effectsPC12 cell death[19,20,21]
Luteolin
Apigenin
(plant flavones)
Attenuation of cell death, caspase-3 and PARP-1 activation, mitigation of LC3 conversion and ROS production, activation of Nrf2 signalingPC12 cells with cell viability[22]
Piceatannol
(P. edulis or
G. parvifolium)
Cytoprotective effect, restoration of PARP cleavage and Bcl-2 expression, down-regulation of p-JNKPC12 cell death and nuclear condensation[25]
Citri reticulatae viride pericarpiumAnti-inflammationPC12 cells with inflammatory injury[27]
Cocoa procyanidin fraction
Procyanidin B2
Attenuation of nuclear condensation, apoptotic cell death and ROS accumulation, blockade of MKK4 activityPC12 cell death and nuclear condensation[28]
Trans-resveratrol
(grapevinele)
Countering the cytotoxic response, attenuation of apoptotic neurodegenerationPC12 cells with cytotoxicity [30]
Sulforaphane
(crucifers such as broccoli, cabbages and olives)
Carnosic acid
(R. officinalis)
Increase of mitochondrial respiration
Nrf2/ARE induction
preventing against mitotoxic effect
Young adult male CF-1 mice
Isolated cortical mitochondria
with inhibition of mitochondrial respiration
[14]
Kaempferol
(flavonoid in many medicinal plants)
Suppression of apoptosis and p-JNK, inhibition of NOX activationPC12 cells with apoptosis
Neuron-like cells
with NOX-mediated neurodegeneration
[13]
Prevention of eye damage
Berberine
(C. chinesis)
Restoration of autophagy, inhibition of diabetic retinopathyConfluent human retinal Müller cells with cell death[55]
Cyanidin-3-glucoside
(plant fruits
mulberry or L. caerulea)
Reduction of apoptosis ratio, inflammation and angiogenesisARPE-19 cells
with apoptosis, inflammatory damage and angiogenesis
[12,63]
Cyanidin-3-glucosideInhibition of NLRP3 inflammasome activation
Regulation of JNK-c-Jun/AP-1 pathway
ARPE-19 cells with inflammation[64]
QuercetinAnti-inflammation, improvement of cell membrane integrity and mitochondrial function, decrease of IL-6, IL-8 and MCP-1 production, regulation of MAPK pathwayARPE-19 cells with cytotoxicity[58,65]
Protection of cardiovascular injury
Oil of T. capitataPrevention of cell death, mitochondrial membrane potential loss and ROS generationPrimary cultures of neonatal rat cardiomyocytes with cell death [15]
Ethanolic and methanolic extracts of olive leaf
(O. europaea)
Inhibition of apoptosis, ROS production, viability impairment, mitochondrial dysfunction and pro-apoptotic activation, reduction of phosphorylation of stress-activated transcription factors Rat cardiomyocytes with cell death[68]
Oleuropein
Hydroxytyrosol Quercetin
(olive leaf)
Prevention of carbonyl stress and toxicity, regulation of cellular redox statusRat cardiomyocytes
with cell death
[68]
G. biloba leaf extractReduction of ox-LDL, attenuation of MMP-1 production, inhibition of the tyrosine-phosphorylated form of platelet-derived growth factor receptor beta activation Human coronary smooth muscle cells with injury[76]
O. cladodes powder
(containing phenolic acid and flavonoids)
Protection against toxicityNormal (Apc +/+) and preneoplastic (Apc min/+) immortalized epithelial colon cells with toxicity[77]
Protection against liver injury
Fine root extract of ginseng with ginsenosides profiles
Methanolic extract of the main root
Inhibitory capacity against DNA damage HepG2 cells
with DNA damage
[80]
Tanshinone II-A
(S. miltiorrhiza)
Alleviation of hepatocyte damage
up-regulation of PPARα, and scavenging 4-HNE
NCTC 1469 cells with damage[85]
7- Hydroxycoumain
(C. lansium, P. forrestii, A. argyi, and P. purpurea)
Hepatoprotection via AKR7A2 inductionHepG2 cells with cytotoxicity [90]
Improvement of energy metabolism disorder
Carnosic acid
(R. officinalis)
Reduction of free fatty acid release, activation of pTyr632 IRS-1 and p-Akt, pSer307IRS-1, suppression of the PKA/HSL pathway activation, decrease of p-AMPK and acetyl-CoA carboxylase, alleviation of insulin resistance3T3-L1 adipocytes with insulin signaling impairment[16]
Carnosic acidAttenuation of free fatty acid release, up-regulation of GST, reduction of 4-HNE-conjugated proteins attenuation of the lipolytic responseHuman subcutaneous adipocytes with lipolysis [16]
4-Hydroxytyrosol
(olive leaf)
Protection of red blood cells with oxidative damageHyperlipemic patients[112]
Repair of other disorders
A. veraAntioxidant capacity for the reduction of ROS
and 4-HNE-protein adducts
HeLa, HMEC, HaCat, and HOS cells with over-production of ROS and -HNE-protein adducts[113]
Capsaicin
(chili peppers)
Curcumin (turmeric) Polyphenols
G. biloba extract P. leucotomos extract
Inhibition of oxidative stress and cell apoptosisHuman melanocytes with oxidative stress and apoptosis[116]

Share and Cite

MDPI and ACS Style

Wang, F.-X.; Li, H.-Y.; Li, Y.-Q.; Kong, L.-D. Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects? Biomolecules 2020, 10, 146. https://doi.org/10.3390/biom10010146

AMA Style

Wang F-X, Li H-Y, Li Y-Q, Kong L-D. Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects? Biomolecules. 2020; 10(1):146. https://doi.org/10.3390/biom10010146

Chicago/Turabian Style

Wang, Fei-Xuan, Hong-Yan Li, Yun-Qian Li, and Ling-Dong Kong. 2020. "Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects?" Biomolecules 10, no. 1: 146. https://doi.org/10.3390/biom10010146

APA Style

Wang, F. -X., Li, H. -Y., Li, Y. -Q., & Kong, L. -D. (2020). Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects? Biomolecules, 10(1), 146. https://doi.org/10.3390/biom10010146

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop